CERENOME, INC.
For the period ended Aug 14, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 14, 2026 · Filed Aug 14, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Data & Artificial Intelligence
Data & Artificial Intelligence
Partnered with Ephemeral Technologies to develop native artificial intelligence, a corporate operating system and data infrastructure designed to integrate therapeutic, diagnostic and bioinformatic data sets and to facilitate advanced data analytics and machine learning across Cerenome’s CNS oncology platform
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.